Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus

Anja Roden, Michele R. Erickson-Johnson, Eunhee S. Yi, Joaquín J. García

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Primary thymic mucoepidermoid carcinoma (TMEC) is rare. High-grade TMEC can be difficult to distinguish from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. A strong association between mucoepidermoid carcinoma (MEC) and t(11;19)(q21;p13) has been observed in other anatomical sites. Although this translocation is largely considered a disease-defining event for MEC, its incidence in TMEC has not been explored. In this study, we evaluate the value of identifying MAML2 rearrangement by fluorescence in situ hybridization (FISH) to distinguish TMEC from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. Cases of TMEC, moderate to poorly differentiated squamous cell carcinoma, and adenosquamous carcinoma were re-reviewed by 3 surgical pathologists and classified according to the current World Health Organization classification of thymic tumors (2004). Cases of TMEC were histologically graded using the Brandwein system. FISH was used to detect MAML2 rearrangements using a break-apart probe. FISH for MAML2 rearrangement was performed on cases of TMEC (n = 2), thymic squamous cell carcinoma (n = 5), and thymic adenosquamous carcinoma (n = 3). The 2 cases of TMEC showed MAML2 rearrangement. All other tested cases did not show rearrangement of MAML2. In conclusion, using FISH to identify MAML2 rearrangement is a valuable diagnostic tool in the evaluation of thymic malignancies, specifically, distinguishing TMEC from squamous cell carcinoma and adenosquamous carcinoma. These findings also suggest that TMEC has both histomorphologic and cytogenetic similarities to cases of MEC arising from other anatomical sites.

Original languageEnglish (US)
Pages (from-to)2799-2805
Number of pages7
JournalHuman Pathology
Volume44
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Mucoepidermoid Carcinoma
Thymoma
Thymus Gland
Adenosquamous Carcinoma
Squamous Cell Carcinoma
Fluorescence In Situ Hybridization
Thymus Neoplasms
Cytogenetics

Keywords

  • Fluorescence in situ hybridization
  • MAML2
  • Mucoepidermoid carcinoma
  • Thymic carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus. / Roden, Anja; Erickson-Johnson, Michele R.; Yi, Eunhee S.; García, Joaquín J.

In: Human Pathology, Vol. 44, No. 12, 12.2013, p. 2799-2805.

Research output: Contribution to journalArticle

Roden, Anja ; Erickson-Johnson, Michele R. ; Yi, Eunhee S. ; García, Joaquín J. / Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus. In: Human Pathology. 2013 ; Vol. 44, No. 12. pp. 2799-2805.
@article{4a6215f6893e4cd68caf31d438f41df8,
title = "Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus",
abstract = "Primary thymic mucoepidermoid carcinoma (TMEC) is rare. High-grade TMEC can be difficult to distinguish from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. A strong association between mucoepidermoid carcinoma (MEC) and t(11;19)(q21;p13) has been observed in other anatomical sites. Although this translocation is largely considered a disease-defining event for MEC, its incidence in TMEC has not been explored. In this study, we evaluate the value of identifying MAML2 rearrangement by fluorescence in situ hybridization (FISH) to distinguish TMEC from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. Cases of TMEC, moderate to poorly differentiated squamous cell carcinoma, and adenosquamous carcinoma were re-reviewed by 3 surgical pathologists and classified according to the current World Health Organization classification of thymic tumors (2004). Cases of TMEC were histologically graded using the Brandwein system. FISH was used to detect MAML2 rearrangements using a break-apart probe. FISH for MAML2 rearrangement was performed on cases of TMEC (n = 2), thymic squamous cell carcinoma (n = 5), and thymic adenosquamous carcinoma (n = 3). The 2 cases of TMEC showed MAML2 rearrangement. All other tested cases did not show rearrangement of MAML2. In conclusion, using FISH to identify MAML2 rearrangement is a valuable diagnostic tool in the evaluation of thymic malignancies, specifically, distinguishing TMEC from squamous cell carcinoma and adenosquamous carcinoma. These findings also suggest that TMEC has both histomorphologic and cytogenetic similarities to cases of MEC arising from other anatomical sites.",
keywords = "Fluorescence in situ hybridization, MAML2, Mucoepidermoid carcinoma, Thymic carcinoma",
author = "Anja Roden and Erickson-Johnson, {Michele R.} and Yi, {Eunhee S.} and Garc{\'i}a, {Joaqu{\'i}n J.}",
year = "2013",
month = "12",
doi = "10.1016/j.humpath.2013.07.031",
language = "English (US)",
volume = "44",
pages = "2799--2805",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus

AU - Roden, Anja

AU - Erickson-Johnson, Michele R.

AU - Yi, Eunhee S.

AU - García, Joaquín J.

PY - 2013/12

Y1 - 2013/12

N2 - Primary thymic mucoepidermoid carcinoma (TMEC) is rare. High-grade TMEC can be difficult to distinguish from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. A strong association between mucoepidermoid carcinoma (MEC) and t(11;19)(q21;p13) has been observed in other anatomical sites. Although this translocation is largely considered a disease-defining event for MEC, its incidence in TMEC has not been explored. In this study, we evaluate the value of identifying MAML2 rearrangement by fluorescence in situ hybridization (FISH) to distinguish TMEC from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. Cases of TMEC, moderate to poorly differentiated squamous cell carcinoma, and adenosquamous carcinoma were re-reviewed by 3 surgical pathologists and classified according to the current World Health Organization classification of thymic tumors (2004). Cases of TMEC were histologically graded using the Brandwein system. FISH was used to detect MAML2 rearrangements using a break-apart probe. FISH for MAML2 rearrangement was performed on cases of TMEC (n = 2), thymic squamous cell carcinoma (n = 5), and thymic adenosquamous carcinoma (n = 3). The 2 cases of TMEC showed MAML2 rearrangement. All other tested cases did not show rearrangement of MAML2. In conclusion, using FISH to identify MAML2 rearrangement is a valuable diagnostic tool in the evaluation of thymic malignancies, specifically, distinguishing TMEC from squamous cell carcinoma and adenosquamous carcinoma. These findings also suggest that TMEC has both histomorphologic and cytogenetic similarities to cases of MEC arising from other anatomical sites.

AB - Primary thymic mucoepidermoid carcinoma (TMEC) is rare. High-grade TMEC can be difficult to distinguish from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. A strong association between mucoepidermoid carcinoma (MEC) and t(11;19)(q21;p13) has been observed in other anatomical sites. Although this translocation is largely considered a disease-defining event for MEC, its incidence in TMEC has not been explored. In this study, we evaluate the value of identifying MAML2 rearrangement by fluorescence in situ hybridization (FISH) to distinguish TMEC from poorly differentiated squamous cell carcinoma and adenosquamous carcinoma. Cases of TMEC, moderate to poorly differentiated squamous cell carcinoma, and adenosquamous carcinoma were re-reviewed by 3 surgical pathologists and classified according to the current World Health Organization classification of thymic tumors (2004). Cases of TMEC were histologically graded using the Brandwein system. FISH was used to detect MAML2 rearrangements using a break-apart probe. FISH for MAML2 rearrangement was performed on cases of TMEC (n = 2), thymic squamous cell carcinoma (n = 5), and thymic adenosquamous carcinoma (n = 3). The 2 cases of TMEC showed MAML2 rearrangement. All other tested cases did not show rearrangement of MAML2. In conclusion, using FISH to identify MAML2 rearrangement is a valuable diagnostic tool in the evaluation of thymic malignancies, specifically, distinguishing TMEC from squamous cell carcinoma and adenosquamous carcinoma. These findings also suggest that TMEC has both histomorphologic and cytogenetic similarities to cases of MEC arising from other anatomical sites.

KW - Fluorescence in situ hybridization

KW - MAML2

KW - Mucoepidermoid carcinoma

KW - Thymic carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84888057919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888057919&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2013.07.031

DO - 10.1016/j.humpath.2013.07.031

M3 - Article

C2 - 24134933

AN - SCOPUS:84888057919

VL - 44

SP - 2799

EP - 2805

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 12

ER -